NLRP3 and colorectal carcinoma: Although NLRP3 has been shown to be associated with EMT in CRC patients18,19 and several reports have correlated the secretion of IL-1β with EMT, tumor progression and metastasis20–22, the underlying molecular mechanism in CRC remains unknown.